Related Experiment Video
Updated: Jun 1, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
What every emergency nurse needs to know about aspirin: an update
Sheila A Turris1, Sheila Finamore
1Affiliate Faculty, University of British Columbia, Central Health Center, 6th Floor - 132 West Esplanade, North Vancouver, British Columbia, Canada V7M 1A2.
Abstract:
In 2005, we presented a manuscript about the use of aspirin (ASA) in the setting of the Emergency Department (ED). We now write to report recent developments in our understanding about ASA and individual responses to the medication. The phenomenon of aspirin resistance is explored.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Coronary Syndrome IV: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome V: Nursing Management
Angina V: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention

